SCHEMBL4194037

SCHEMBL4194037

C[C@@H](CC1CCCC1)NCc1ccccc1NS(=O)(=O)c1ccc(-c2cccc(F)c2)s1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GHSR Q92847 6/20 0.44
KDM4E B2RXH2 1/20 0.35
PKM P14618 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35
PFKFB3 Q16875 2/20 0.35
USP30 Q70CQ3 2/20 0.34
MMP1 P03956 2/20 0.34
MMP13 P45452 2/20 0.34
PTGES2 Q9H7Z7 1/20 0.33
EDNRB P24530 1/20 0.33
EDNRA P25101 1/20 0.33
TP53 P04637 1/20 0.33
POLB P06746 1/20 0.33
MAPT P10636 1/20 0.33
CCNE2 O96020 1/20 0.32
CCNA2 P20248 1/20 0.32
CCNE1 P24864 1/20 0.32
CDK2 P24941 1/20 0.32
CCNA1 P78396 1/20 0.32
F2 P00734 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4197519 0.99 GHSR (0.43) GHSRKDM4EPKMRXFP1PFKFB3
SCHEMBL4203709 0.99 GHSR (0.43) GHSRKDM4EPKMRXFP1PFKFB3
SCHEMBL4197564 0.92 KDM4E (0.39) GHSRKDM4EPKMRXFP1PFKFB3
SCHEMBL4185970 0.91 KDM4E (0.40) GHSRKDM4EPKMRXFP1PFKFB3
SCHEMBL4196692 0.89 PFKFB3 (0.41) GHSRKDM4EPKMRXFP1PFKFB3
SCHEMBL4189854 0.89 PFKFB3 (0.41) GHSRKDM4EPKMRXFP1PFKFB3
SCHEMBL4198208 0.88 ALDH1A1 (0.38) GHSRKDM4EPKMRXFP1PFKFB3
SCHEMBL4198289 0.88 GHSR (0.38) GHSRKDM4EPKMMMP1MMP13
SCHEMBL4195119 0.88 GHSR (0.38) GHSRKDM4EPKMMMP1MMP13
SCHEMBL4198366 0.88 KDM4E (0.35) GHSRKDM4EPKMRXFP1USP30

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1879877-B1 ANTIMICROBIAL AGENTS RANBAXY LAB LTD (IN) 2013-01-02 EP claimed
US-8076370-B2 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2011-12-13 US claimed
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US claimed
EP-1879877-B1 ANTIMICROBIAL AGENTS RANBAXY LAB LTD (IN) 2013-01-02 EP disclosed
US-8076370-B2 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2011-12-13 US disclosed
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215764-A1 Antimicrobial agents TUFM, RPS17, HARS1 GHSR 3645/4885KDM4E 3328/4885PKM 1855/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.